Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lin, Juntang  [Clear All Filters]
2024
Zhang H, Lin J, Yahaya BHisham. Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma. J Cancer Res Clin Oncol. 2024;150(2):44.
2023
Zhang S, Liu Q, Chang M, Pan Y, Yahaya BHisham, Liu Y, Lin J. Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis. Cell Death Dis. 2023;14(5):340.
Yang M, Zhao Y, Li X, Li H, Cheng F, Liu Y, Jia Z, He Y'nan, Lin J, Guan L. Conditioned medium of human menstrual blood-derived endometrial stem cells protects against cell inflammation and apoptosis of Npc1 N2a cells. Metab Brain Dis. 2023.
Zhang S, Zhang R, Yin X, Lu Y, Cheng H, Pan Y, Liu Y, Lin J. MenSCs Transplantation Improve the Viability of Injured Endometrial Cells Through Activating PI3K/Akt Pathway. Reprod Sci. 2023.
Li H, Wei J, Zhang Z, Li J, Ma Y, Zhang P, Lin J. Menstrual blood-derived endometrial stem cells alleviate neuroinflammation by modulating M1/M2 polarization in cell and rat Parkinson's disease models. Stem Cell Res Ther. 2023;14(1):85.
Xu Z, Zhang G, Zhang X, Lei Y, Sun Y, He Y'nan, Yang F, Nan WB, Xing X, Li Y, et al. Menstrual blood-derived endometrial stem cells inhibit neuroinflammation by regulating microglia through the TLR4/MyD88/NLRP3/Casp1 pathway. Int J Biochem Cell Biol. 2023:106386.
Guan L, Jia Z, Xu K, Yang M, Li X, Qiao L, Liu Y, Lin J. Npc1 gene mutation abnormally activates the classical Wnt signalling pathway in mouse kidneys and promotes renal fibrosis. Anim Genet. 2023.
Zang X, Wang Z, Li Y, Gao H, Guo J, Jin W, Chang C, Lin J, Zhu K, Xu C. Regulation of Hepatocytes in G0 and G1 Phases by NOTCH3 mRNA, miR-369-3p, and rno-Rmdn2_0006 during the Initial Stage of Rat Liver Regeneration. Genet Res (Camb). 2023;2023:8779758.
2022
Dama G, Du J, Zhu X, Liu Y, Lin J. Bone marrow-derived mesenchymal stem cells: A promising therapeutic option for the treatment of diabetic foot ulcers. Diabetes Res Clin Pract. 2022:110201.
Du J, Jiang Y, Liu X, Ji X, Xu B, Zhang Y, Liu Y, Zhang T, Lin J. HGF secreted by menstrual blood-derived endometrial stem cells ameliorates non-alcoholic fatty liver disease through downregulation of hepatic Rnf186. Stem Cells. 2022.
Shang L, Zhang R, Yan J, Lu Y, Zhang S, Sun Y, Cheng H, Liu Y, Lin J. Sustainable Production and Activity Determination of Serum-Free Conditioned Medium from Menstrual Blood-Derived Endometrial Stem Cells. Appl Biochem Biotechnol. 2022.
2021
Guan L, Han Y, Yang C, Lu S, Du J, Li H, Lin J. CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders. Mol Neurobiol. 2021.
Guo R, Zhang D, Zhang C, Yang Y, Liu H, Yang Y, Lin J. Immunotoxin IHP25-BT with low immunogenicity and off-target toxicity inhibits the growth and metastasis of trastuzumab-resistant tumor cells. Int J Pharm. 2021:121081.
2019
Du J, Ji Y, Qiao L, Liu Y, Lin J. Cellular endo-lysosomal dysfunction in the pathogenesis of non-alcoholic fatty liver disease. Liver Int. 2019.
Liu Q, Du J, Fan J, Li W, Guo W, Feng H, Lin J. Generation and Characterization of Induced Pluripotent Stem Cells from Mononuclear Cells in Schizophrenic Patients. Cell J. 2019;21(2):161-168.
Yang C, Li X, Zhang B, Fu S, Li S, Shen J, Guan L, Qiao L, Lin J. The Mechanism of Rap1 Regulates N-cadherin to Control Neuronal Migration. J Mol Neurosci. 2019.
Liu Y, Niu R, Li W, Lin J, Stamm C, Steinhoff G, Ma N. Therapeutic potential of menstrual blood-derived endometrial stem cells in cardiac diseases. Cell Mol Life Sci. 2019.
2018
Zhu X, Liu Y, Yu J, Du J, Guo R, Feng Y, Zhong G, Jiang Y, Lin J. LncRNA HOXA-AS2 represses endothelium inflammation by regulating the activity of NF-κB signaling. Atherosclerosis. 2018;281:38-46.
Zhu X, Du J, Yu J, Guo R, Feng Y, Qiao L, Xu Z, Yang F, Gong G, Liu F, et al. LncRNA NKILA regulates endothelium inflammation by controlling a NF-κB/KLF4 positive feedback loop. J Mol Cell Cardiol. 2018.
2016
Chen H, Nan WB, Wei X, Wang Y, Lv F, Tang H, Li Y, Zhou C, Lin J, Zhu W, et al. Toxicity, pharmacokinetics, and in vivo efficacy of biotinylated chitosan surface-modified PLGA nanoparticles for tumor therapy. Artif Cells Nanomed Biotechnol. 2016:1-8.